IonFlux Mercury
Fluxion Biosciences has signed a distribution agreement with Harvard Biosciences. The distribution agreement covers Fluxion's BioFlux and IonFlux platforms for sale to Harvard Bioscience's customers in North America.
Fluxion's BioFlux system is used by researchers for automated, high throughput studies of cell-cell interactions, and complements Harvard Bio's existing perfusion systems. The IonFlux system is used by pharmaceutical companies and academic labs for ion channel research and drug discovery. IonFlux utilizes a "plate reader" format for simple user operation, yet provides the flexibility to run highly complex assays for applications such as ligand-gated ion channels. IonFlux is a natural addition to Harvard Bio's broad portfolio of electrophysiology products.
"Harvard Bioscience is an ideal partner to distribute the IonFlux and BioFlux systems. They have developed a well-deserved reputation for delivering top-quality products and services to the electrophysiology market," Jeff Jensen, CEO of Fluxion said.